Semilobar holoprosencephaly in a 12-month-old baby boy born to a primigravida patient with type 1 diabetes mellitus: a case report by unknown
CASE REPORT Open Access
Semilobar holoprosencephaly in a 12-
month-old baby boy born to a primigravida
patient with type 1 diabetes mellitus: a
case report
Pedro Pallangyo1*, Frederick Lyimo2, Paulina Nicholaus1, Hilda Makungu2, Maria Mtolera2 and Isaac Mawenya3
Abstract
Background: Holoprosencephaly is a rare spectrum of cephalic disorders resulting from a failure or incomplete
division of the embryonic forebrain into distinct cerebral hemispheres. It is the most common brain malformation
with an incidence of 1:250 during embryogenesis; however, owing to the associated high rates of spontaneous
abortion the incidence is 1:16,000 among live deliveries. Pathogenesis of holoprosencephaly is complex and
heterogeneous involving genetic abnormalities, teratogenic exposures, and syndromic associations. Among the
teratogenic exposures, maternal diabetes is a well-established risk factor associated with a 200-fold increased
incidence of holoprosencephaly.
Case presentation: We report a case of a delayed diagnosis of semilobar holoprosencephaly in a 12-month-old
baby boy of African descent who presented to us with a history of global developmental delay, erratic sleep
patterns, and poor weight gain. He was born to a type 1 diabetes mellitus mother at 39+ weeks by emergency
cesarean section due to fetal distress and breech presentation. The baby weighed 2315 g and had Apgar scores of
6/10 and 8/10 at 1 and 5 minutes respectively. A physical examination done at 12 months of age revealed a
small-for-age child with a developmental age of 2 months. He had normal facies but a neurological examination
revealed hypotonia in all four limbs. The rest of systemic examination was unremarkable. Hematological and
biochemical investigations revealed normal findings except for iron deficiency anemia. The child also underwent
magnetic resonance imaging of his brain which revealed distinctive features of semilobar holoprosencephaly. He was
treated for iron deficiency anemia with Hemovit syrup (ferric ammonium citrate, folic acid, pyridoxine hydrochloride,
cyanocobalamin, and zinc sulfate) 10 ml thrice daily, ferrous sulfate 10 mg once daily, folic acid 1 mg once daily, and
multivitamin syrup 5 ml once daily. Furthermore, nutritional and genetic counseling was offered to his parents.
Conclusions: In conclusion, although rare, holoprosencephaly is the commonest structural anomaly of the brain with a
complex and multifactorial etiopathogenesis. It is prudent to diagnose it prenatally, classify its severity, and forge its
prognosis so that parents are counseled early enough to make informed decisions especially where termination of
pregnancy may be implicated.
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Background
Congenital structural malformations of the central nervous
system are responsible for a considerable morbidity and
mortality in childhood with resultant long-term psycho-
logical, social, and financial implications for the survivors
and their families. Holoprosencephaly (HPE) encompasses
a continuum of brain malformations characterized by a
failed or incomplete cleavage of the embryonic forebrain
into distinct cerebral hemispheres often occurring by the
fourth week of gestation [1–8]. It is the most common
brain malformation with an incidence of 1:250 during
embryogenesis; however, owing to the associated high rates
of spontaneous abortion the incidence of HPE is 1:16,000
among live deliveries [3–8]. Classically, HPE is categorized
into three main subtypes in order of decreasing severity:
alobar, semilobar, and lobar.
The etiopathogenesis of HPE is multifactorial involving
the interplay of various environmental and genetic factors.
Neurodevelopmental delay is present in virtually all
affected children while other manifestations including
hypotonia, seizures, aspiration pneumonia, pituitary
dysfunction, and failure to thrive are not uncommon
[6, 8]. Owing to a shared embryonic origin between
the forebrain and midface (that is, prechordal mesoderm),
over three-quarters of individuals with HPE have
concomitant craniofacial anomalies some of which are in-
compatible with life (for example, cyclopia) [2, 6, 8]. Diag-
nosis of HPE is usually made by prenatal transabdominal
ultrasound or a computed tomography (CT) scan/magnetic
resonance imaging (MRI) and its management is basically
supportive. Survival and developmental outcome is gen-
erally poor and is dictated by the HPE subtype and the
degree of the accompanying craniofacial dysmorphism [8].
We report a case of semilobar HPE in a 12-month-old
baby boy of African descent who was born to a mother
with type 1 diabetes mellitus.
Case presentation
A 12-month-old baby boy of African descent presented
to us with a history of global developmental delay, erratic
sleep patterns, and poor weight gain. He was the first born
to a 28-year-old woman with type 1 diabetes mellitus diag-
nosed at the age of 9. The mother attended antenatal
clinic from the 16th week of gestation and received all
routine antenatal care as per the Tanzanian protocol
(antihelminthics, antimalarial medications, hematinics,
and tetanus toxoid). She tested negative for human im-
munodeficiency virus (HIV), hepatitis B and C, and syphilis.
The mother denied history of toxoplasmosis, other (syphilis,
varicella-zoster, parvovirus B19), rubella, cytomegalovirus,
Fig. 1 Brain magnetic resonance imaging (fluid-attenuated inversion recovery) displaying an incompletely formed interhemispheric fissure (arrow 1)
and partial fusion of the frontal lobe (arrow 2)
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and herpes (TORCH) infections, trauma, or chronic drug
use; however, she had a urinary tract infection during her
first trimester which was successfully treated with oral
cephalexin 500 mg four times a day for 5 days. Apart from
the insulin-dependent diabetes mellitus, no other history of
familial genetic disorders was elicited. Sonographic evalu-
ation at 16th and 36th week of gestation revealed a normal
singleton pregnancy. Despite a fairly good sugar control be-
fore pregnancy, the mother had poor glycemic control dur-
ing pregnancy and her glycated hemoglobin (HbA1C) taken
at 7 and 29 weeks of gestation was 8.3% and 7.9% respect-
ively. She gave birth at 39+ weeks by emergency cesarean
section due to fetal distress and breech presentation. The
baby weighed 2315 g and had Apgar scores of 6/10 and
8/10 at 1 and 5 minutes respectively. His head circumference
at birth was 38.9 cm (97th percentile). Chromosome ana-
lysis (karyotyping) is not a routine practice in Tanzania
and it was not performed.
The boy weighed 8.5 kg at 6 months, which was the
exact same weight measured during his visit to our insti-
tution at 12 months of age. His head circumference at 1
year was 49.1 cm (99th percentile). He had stable vital
signs but a physical examination revealed a small-for-age
child with conjunctival and palmar pallor. All his growth
parameters were below the 5th percentile and he had a
developmental age of 2 months. He scored 4 on neuro-
cognitive assessment using the Carter Neurocognitive
Assessment Severity Scale. He had normal facies but a
neurological examination revealed hypotonia in all four
limbs. Other systemic examinations were unremarkable.
He underwent a series of blood work-up, cardiac echocar-
diography (ECHO), and renal ultrasound all of which re-
vealed normal findings except for iron deficiency anemia:
hemoglobin (Hb) 8.7 g/dL, mean corpuscular hemoglobin
(MCH) 21 pg/cell, mean corpuscular volume (MCV) 69 fL,
and red cell distribution width (RDW) 15.1%. The child
also underwent MRI of his brain which revealed an incom-
pletely formed interhemispheric fissure, a monoventricle
with partially developed temporal and occipital horns,
partial fusion of his frontal lobe, hypoplastic corpus
callosum, and volume loss bilaterally at temporal lobes
(Figs. 1, 2, and 3). His cerebellum and brain stem appeared
normal. Based on the clinical presentation and MRI find-
ings the diagnosis of semilobar HPE was entertained. The
Fig. 2 Brain magnetic resonance imaging (fluid-attenuated inversion recovery) displaying a mono ventricle with partially developed temporal and
occipital horns (arrow 1)
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child was treated for iron deficiency anemia with Hemovit
syrup (ferric ammonium citrate, folic acid, pyridoxine
hydrochloride, cyanocobalamin, and zinc sulfate) 10 ml
thrice daily, ferrous sulfate 10 mg once daily, folic acid 1
mg once daily, and multivitamin syrup 5 ml once daily.
Furthermore, nutritional and genetic counseling was
offered to his parents.
The child continued to be attended by a developmental
pediatrician and pediatric dietician on a regular basis at
our institution. An assessment conducted at 12 months
post-initial visit showed improvement in his neurocognitive
status (Carter Neurocognitive Assessment Severity Scale
score = 2). Furthermore, he had attained an acceptable
weight for his age (12.6 kg) and his sleeping pattern was
stable. In the long run, he is scheduled for both physical
and occupational therapy aiming to enhance his motor
skills and maximize functional independence.
Discussion
HPE is a rare spectrum of cephalic disorders resulting from
a failure or incomplete division of the embryonic forebrain
into distinct cerebral hemispheres. In the semilobar HPE
subtype, the cerebral hemispheres separate posteriorly but
not anteriorly. The pathogenesis of HPE is complex and
heterogeneous involving genetic abnormalities [9–11],
teratogenic exposures [12–17], and syndromic associa-
tions [18–23]. Among the teratogenic exposures, maternal
hyperglycemia is an established risk factor for HPE
[1, 8, 24]. Barr et al. found a 200-fold increased risk
for HPE among babies born to diabetic mothers compared
to those of diabetes-free mothers [24]. In the case pre-
sented, the mother was known to have insulin-dependent
diabetes mellitus and her glycemic control during preg-
nancy was poor. Long-term use of drugs including aspirin
[12], statins [13], misoprostol [14], methotrexate [15],
retinoic acid [16], and alcohol [17] have shown increased
risk in the animal model, results which are yet to be repli-
cated in humans [1, 8]. However, in the case presented the
mother denied chronic use of medications apart from
insulin injections for her diabetes. Moreover, TORCH
infections early in pregnancy may potentially affect cerebral
embryogenesis leading to HPE [1, 8]; a possibility of such
infections in our case was, however, ruled out. Although
craniofacial anomalies frequently coexist with HPE, they are
usually mild or absent in the semilobar subtype as was wit-
nessed in this case. Such anomalies include microcephaly,
single central maxillary incisor, cleft lip and palate, flat nose,
absent nasal bridge, microphthalmia, absence of lateral
philtral ridges, absence of the superior lingual frenulum,
iris coloboma, and cyclopia [2, 5, 7, 8].
Diagnosis of HPE is usually made prenatally in women
with a high index of suspicion. Our case, however, was not
diagnosed until the age of 1 year despite evidence of hyper-
glycemia exposure in utero and infancy symptomatology
Fig. 3 Brain magnetic resonance imaging (T2 weighted) displaying a partially formed corpus callosum (arrow 1)
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suggestive of HPE. However, HPE prognosis remains gener-
ally poor, with the type of HPE and coexisting craniofacial
anomalies as key prognostic indicators. For instance, less
than 20% of patients with the alobar subtype will survive to
12 months while approximately 50% with the isolated semi-
lobar form will survive beyond 1 year [3]. Management of
HPE although mainly supportive requires a multidiscip-
linary approach aiming at managing symptoms and
complications, and avoiding added disability to improve
the overall quality of life. This case despite its typical
presentation was actually the first case of HPE to be
diagnosed and documented in Tanzania. It is the authors’
hope that upon its publication this case report will sensitize
practitioners especially in resource poor settings to raise an
index of suspicion for HPE particularly in women of
high risk.
Conclusions
In conclusion, although rare, HPE is the commonest
structural anomaly of the brain with a complex and
multifactorial etiopathogenesis. It is prudent to diagnose
it prenatally, classify its severity, and forge its prognosis
so that parents are counseled early enough to make in-
formed decisions especially where termination of pregnancy
may be implicated. Furthermore, in cases with somewhat
better prognosis, thorough counseling is crucial to prepare
expectant parents to understand, accept, and prepare for
the challenges in raising a child with HPE.
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